dexmedetomidine has been researched along with Esophageal Neoplasms in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 8 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, XJ; Cao, FJ; Li, D; Liu, S; Song, Y; Yu, XJ; Zhang, L; Zhang, W; Zuo, ZG | 1 |
| Che, J; Liu, M; Lv, H | 1 |
| Chai, X; Geng, Q; Hu, Y; Shi, S; Tang, C; Wang, H; Wang, J; Wang, S; Wei, Z; Zhang, Z | 1 |
| Bai, Y; He, H; Huang, L; Liu, W; Zhang, P | 1 |
| Gondo, T; Hashimoto, H; Nakamura, K; Sonoo, T | 1 |
| Gong, Z; Li, J; Long, X; Ma, L; Tang, Y; Wei, H; Yu, J | 1 |
| Arimoto, J; Ashikari, K; Chiba, H; Fuyuki, A; Higurashi, T; Kanoshima, K; Matsuura, T; Misawa, N; Nakajima, A; Nonaka, T; Ohkubo, H; Takatsu, T; Yoshihara, T | 1 |
| Hu, Y; Long, YX; Qiu, LL; Yang, T; Zhao, ZF | 1 |
| Egi, M; Fujimoto, D; Izuta, S; Mizobuchi, S; Obata, N | 1 |
| Qiao, Y; Wu, Z; Zhang, H; Zhao, X | 1 |
| Fujisaki, J; Hirasawa, T; Horiuchi, Y; Ishiyama, A; Omae, M; Sano, H; Tsuchida, T; Yamamoto, Y; Yokota, M; Yoshimizu, S; Yoshio, T | 1 |
| Liu, HL; Zhang, Y; Zheng, GL | 1 |
5 trial(s) available for dexmedetomidine and Esophageal Neoplasms
| Article | Year |
|---|---|
Dexmedetomidine with sufentanil in intravenous patient-controlled analgesia for relief from postoperative pain, inflammation and delirium after esophageal cancer surgery.
Topics: Administration, Intravenous; Aged; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesics, Opioid; China; Cytokines; Delirium; Dexmedetomidine; Double-Blind Method; Esophageal Neoplasms; Esophagectomy; Female; Health Status; Humans; Inflammation; Inflammation Mediators; Laparoscopy; Male; Middle Aged; Pain, Postoperative; Prospective Studies; Sufentanil; Thoracoscopy; Time Factors; Treatment Outcome | 2020 |
[Dexmedetomidine combined with protective lung ventilation strategy provides lung protection in patients undergoing radical resection of esophageal cancer with one-lung ventilation].
Topics: Dexmedetomidine; Esophageal Neoplasms; Humans; Lung; Malondialdehyde; One-Lung Ventilation | 2020 |
Efficacy of sedation with dexmedetomidine plus propofol during esophageal endoscopic submucosal dissection.
Topics: Conscious Sedation; Dexmedetomidine; Endoscopic Mucosal Resection; Esophageal Neoplasms; Humans; Hypnotics and Sedatives; Propofol; Prospective Studies; Psychomotor Agitation | 2021 |
Efficacy of novel sedation using the combination of dexmedetomidine and midazolam during endoscopic submucosal dissection for esophageal squamous cell carcinoma.
Topics: Aged; Aged, 80 and over; Anesthesia; Case-Control Studies; Dexmedetomidine; Drug Therapy, Combination; Endoscopic Mucosal Resection; Endoscopy; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Humans; Hypnotics and Sedatives; Japan; Male; Midazolam; Middle Aged; Personal Satisfaction; Prospective Studies; Retrospective Studies; Self Report; Surveys and Questionnaires; Treatment Outcome | 2019 |
[Clinical observation of injection of dexmedetomidine in anaesthesia for esophageal cancer operation].
Topics: Adjuvants, Anesthesia; Adult; Aged; Analgesics, Non-Narcotic; Anesthetics, Intravenous; Dexmedetomidine; Esophageal Neoplasms; Female; Fentanyl; Humans; Male; Middle Aged; Propofol | 2011 |
7 other study(ies) available for dexmedetomidine and Esophageal Neoplasms
| Article | Year |
|---|---|
Dexmedetomidine inhibits the growth and metastasis of esophageal cancer cells by down-regulation of lncRNA MALAT1.
Topics: Adenocarcinoma; Animals; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dexmedetomidine; Down-Regulation; Esophageal Neoplasms; Ki-67 Antigen; Mice; MicroRNAs; RNA, Long Noncoding | 2022 |
Dexmedetomidine disrupts esophagus cancer tumorigenesis by modulating circ_0003340/miR-198/HMGA2 axis.
Topics: Animals; Carcinogenesis; Cell Proliferation; Cell Transformation, Neoplastic; Dexmedetomidine; Esophageal Neoplasms; Humans; Mice; MicroRNAs; RNA, Circular | 2022 |
Dexmedetomidine suppresses the progression of esophageal cancer via miR-143-3p/epidermal growth factor receptor pathway substrate 8 axis.
Topics: Adaptor Proteins, Signal Transducing; Analgesics, Non-Narcotic; Animals; Antineoplastic Agents; Apoptosis; Cell Growth Processes; Cell Line, Tumor; Dexmedetomidine; Disease Progression; Down-Regulation; Esophageal Neoplasms; Humans; Mice; MicroRNAs; Neoplasm Metastasis; Signal Transduction; Xenograft Model Antitumor Assays | 2020 |
Chemoradiation therapy for oesophageal cancer with airway stenosis under mechanical ventilation with light sedation using dexmedetomidine alone.
Topics: Airway Obstruction; Chemoradiotherapy; Dexmedetomidine; Esophageal Neoplasms; Humans; Hypnotics and Sedatives; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Respiration, Artificial; Tracheal Neoplasms | 2020 |
Dexmedetomidine represses proliferation and promotes apoptosis of esophageal cancer cells by regulating C-Myc gene expression via the ERK signaling pathway.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Dexmedetomidine; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Esophageal Neoplasms; Extracellular Signal-Regulated MAP Kinases; Humans; Proto-Oncogene Proteins c-myc; Signal Transduction; Tumor Cells, Cultured | 2021 |
[Vital Sign Changes and the Requirement of Analgesics after Discontinuation of Dexmedetomidine in Patients after Esophageal Cancer Surgery.]
Topics: Aged; Analgesics, Non-Narcotic; Blood Pressure; Dexmedetomidine; Esophageal Neoplasms; Female; Heart Rate; Humans; Hypnotics and Sedatives; Male; Middle Aged; Pain, Postoperative; Postoperative Care; Retrospective Studies | 2016 |
Role of dexmedetomidine in reducing the incidence of postoperative cognitive dysfunction caused by sevoflurane inhalation anesthesia in elderly patients with esophageal carcinoma.
Topics: Age Factors; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Anesthesia, General; Anesthetics, Inhalation; Biomarkers; Cognitive Dysfunction; Cytokines; Dexmedetomidine; Esophageal Neoplasms; Female; Humans; Inflammation Mediators; Male; Postoperative Complications; S100 Calcium Binding Protein beta Subunit; Sevoflurane | 2018 |